HTA precedent is everywhere. Almost none of it is queryable.

Every Health Technology Assessment produced in Europe (by UK NICE, National Institute for Health and Care Excellence, G-BA (Germany, Gemeinsamer Bundesausschuss), HAS (France, Haute Autorité de Santé), AIFA (Italy, Agenzia Italiana del Farmaco), AEMPS (Spain, Agencia...

The Great AI Divide

The Illusion of Progress AI is everywhere. In presentations, strategy decks, performance reviews. It writes faster than we do, answers questions instantly, and seems to make organizations more efficient overnight. The promise is seductive: more output, less effort,...

IDMP: We built a map. Pharma needs an instrument.

Two years ago, the IDMP ontology (IDMP-O) won the BioITWorld award [https://pistoiaalliance.org/news/pistoia-alliance-wins-2024-bio-it-world-innovative-practices-award-for-idmp-pre-competitive-collaboration/]. We built the first version at Novartis, released it into...

Driving System Thinking in Pharma

Pharma Organization Change Management – Driving System Thinking in Pharma Why Organizational Change is the Real Challenge   Many organizations in Life Sciences have already invested in data platforms, AI, and increasingly, knowledge graphs (KGs). The...

A Mindset Topology of IT and Business in Pharma

Business & IT: two mindsets, one organization A Story of Two Ways of Thinking In pharmaceutical organizations, innovation often stalls in unexpected places. Not in technology choices, not in data availability, not even in regulatory constraints, it stalls in...